Literature DB >> 1897310

Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha.

Z A Janowicz1, K Melber, A Merckelbach, E Jacobs, N Harford, M Comberbach, C P Hollenberg.   

Abstract

An expression system has been developed for the methylotrophic yeast Hansenula polymorpha and used to co-express both the L (preS1-S2-S) and S hepatitis B surface antigens (HBsAg) under the control of strong methanol-inducible promoters derived from the methanol oxidase and from the formate dehydrogenase genes. A unique feature of this H. polymorpha expression system is the possibility of integrating up to 100 copies of an expression cassette via a multimeric integration mechanism. Several multimeric integrants containing various numbers of L and S expression cassettes were constructed to give a spectrum of strains characterized by different L to S ratios. The expression level of S antigen was 5-8% of the total soluble cell protein. Analysis by sucrose and CsCl density gradient centrifugation and by particle-specific immunoassays demonstrated that the synthesized HBsAg spontaneously assembled into composite subviral particles containing both S and L proteins. Only a minor portion of the L protein was found to be glycosylated. These H polymorpha-derived composite particles can be used for the production of a hepatitis B virus vaccine with the potential for improved immunogenicity due to the presence of a wider spectrum of epitopes and negligible glycosylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1897310     DOI: 10.1002/yea.320070502

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  22 in total

1.  A family of telomere-associated autonomously replicating sequences and their functions in targeted recombination in Hansenula polymorpha DL-1.

Authors:  J H Sohn; E S Choi; H A Kang; J S Rhee; S K Rhee
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

Review 2.  The yeast expression system for recombinant glycosyltransferases.

Authors:  M Malissard; S Zeng; E G Berger
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

Review 3.  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.

Authors:  Wolfram H Gerlich
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

4.  HARO7 encodes chorismate mutase of the methylotrophic yeast Hansenula polymorpha and is derepressed upon methanol utilization.

Authors:  S Krappmann; R Pries; G Gellissen; M Hiller; G H Braus
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

5.  A novel autonomously replicating sequence (ARS) for multiple integration in the yeast Hansenula polymorpha DL-1.

Authors:  J H Sohn; E S Choi; C H Kim; M O Agaphonov; M D Ter-Avanesyan; J S Rhee; S K Rhee
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

6.  Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.

Authors:  R Schirmbeck; K Melber; T Mertens; J Reimann
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Stable multicopy integration of vector sequences in Hansenula polymorpha.

Authors:  R Gatzke; U Weydemann; Z A Janowicz; C P Hollenberg
Journal:  Appl Microbiol Biotechnol       Date:  1995-10       Impact factor: 4.813

8.  Cloning and sequencing of the ura3 locus of the methylotrophic yeast Hansenula polymorpha and its use for the generation of a deletion by gene replacement.

Authors:  A Merckelbach; S Gödecke; Z A Janowicz; C P Hollenberg
Journal:  Appl Microbiol Biotechnol       Date:  1993-11       Impact factor: 4.813

Review 9.  The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

Authors:  Nelson F Eng; Nitin Bhardwaj; Rebecca Mulligan; Francisco Diaz-Mitoma
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

10.  Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.

Authors:  R Schirmbeck; W Böhm; K Ando; F V Chisari; J Reimann
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.